The adaptive immune system, including CD4+ T cells and B cells, has long been implicated in the pathogenesis of multiple sclerosis (MS) (1, 2), a chronic inflammatory demyelinating disease of the central nervous system (CNS). The gene discussed is CD4; the disease is myeloid sarcoma.